ASCIMINIB

ASCIMINIB was reported 3492 times

ASCIMINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CBL GENE MUTATION 1 0.2500
1 ACUTE ASEPTIC ARTHRITIS 1 0.2000
2 MICROVASCULAR CRANIAL NERVE PALSY 3 0.1364
3 BLOOD TEST NORMAL 1 0.0909
4 PHILADELPHIA CHROMOSOME NEGATIVE 2 0.0833
5 PHILADELPHIA CHROMOSOME POSITIVE 58 0.0793
6 POOR PROGNOSIS 2 0.0690
7 PERCUSSION TEST ABNORMAL 2 0.0541
8 CYTOGENETIC ANALYSIS ABNORMAL 51 0.0487
9 GRAFT VERSUS HOST DISEASE ORAL 3 0.0469
10 AUSCULTATION 1 0.0455
11 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 20 0.0448
12 PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA 4 0.0417
13 PANCREATIC TOXICITY 5 0.0413
14 GRAFT VERSUS HOST DISEASE IN EYE 9 0.0390
15 BLAST CELL CRISIS 12 0.0361
16 PENILE DERMATITIS 2 0.0317
17 CHRONIC EOSINOPHILIC LEUKAEMIA 1 0.0312
18 CHRONIC MYELOID LEUKAEMIA RECURRENT 17 0.0311
19 PANCREATIC ENZYMES ABNORMAL 3 0.0306
20 LEUKAEMIC INFILTRATION 4 0.0286
21 BRAIN STEM ISCHAEMIA 5 0.0279
22 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 34 0.0276
23 BASOPHILIA 2 0.0267
24 PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0245
25 PSEUDOPHAKIA 2 0.0230
26 RIGHT VENTRICULAR ENLARGEMENT 7 0.0219
27 HYDROSALPINX 2 0.0217
28 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0211
29 ARTERITIS CORONARY 1 0.0208
30 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 4 0.0197
31 BLAST CELLS 1 0.0192
32 DUODENAL POLYP 4 0.0189
33 CHRONIC MYELOID LEUKAEMIA 87 0.0188
34 BREATH SOUNDS ABSENT 2 0.0182
35 AMMONIA 1 0.0175
36 DRUG RESISTANCE MUTATION 3 0.0169
37 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 4 0.0163
38 PERIPHERAL ARTERY STENOSIS 7 0.0146
39 GENE MUTATION IDENTIFICATION TEST POSITIVE 6 0.0143
40 PARAKERATOSIS 4 0.0123
41 EYELID BLEEDING 2 0.0116
42 B-CELL TYPE ACUTE LEUKAEMIA 8 0.0109
43 CEREBRAL VASOCONSTRICTION 8 0.0108
44 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 6 0.0100
45 INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS 3 0.0097
46 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 25 0.0097
47 MONOCYTOSIS 6 0.0097
48 LIPASE INCREASED 74 0.0096
49 REMISSION NOT ACHIEVED 6 0.0096
50 VIRAL PERICARDITIS 2 0.0096
51 CHLOROMA 4 0.0095
52 LOSS OF THERAPEUTIC RESPONSE 30 0.0094
53 MOYAMOYA DISEASE 2 0.0092
54 GIARDIASIS 3 0.0088
55 NUTRITIONAL CONDITION ABNORMAL 6 0.0086
56 POLYMERASE CHAIN REACTION POSITIVE 3 0.0086
57 PALATAL SWELLING 2 0.0083
58 AMYLASE INCREASED 29 0.0079
59 CREATINE KINASE INCREASED 6 0.0078
60 BLOOD ALKALINE PHOSPHATASE ABNORMAL 7 0.0078
61 CYTOPENIA 95 0.0078
62 BLAST CELL COUNT INCREASED 8 0.0076
63 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 5 0.0076
64 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0074
65 COMPUTERISED TOMOGRAM 1 0.0072
66 TRANSPLANTATION COMPLICATION 3 0.0071
67 CEREBROVASCULAR STENOSIS 1 0.0068
68 NAIL TOXICITY 2 0.0067
69 GASTROINTESTINAL STOMA OUTPUT INCREASED 3 0.0064
70 PROCEDURAL DIZZINESS 2 0.0062
71 BLOOD CHLORIDE ABNORMAL 1 0.0062
72 PANCREATIC ENZYMES INCREASED 9 0.0061
73 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
74 MARROW HYPERPLASIA 4 0.0059
75 CHRONIC LEUKAEMIA 1 0.0057
76 FOETAL EXPOSURE TIMING UNSPECIFIED 4 0.0056
77 ARTERIAL INSUFFICIENCY 1 0.0054
78 ACUTE LYMPHOCYTIC LEUKAEMIA 15 0.0053
79 MUSCLE DISCOMFORT 4 0.0051
80 CENTRAL NERVOUS SYSTEM LEUKAEMIA 2 0.0051
81 DEMYELINATING POLYNEUROPATHY 5 0.0049
82 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
83 ORCHITIS 5 0.0046
84 GASTROINTESTINAL TRACT IRRITATION 5 0.0046
85 GENE MUTATION 9 0.0045
86 HYPERLEUKOCYTOSIS 4 0.0045
87 INTERMITTENT CLAUDICATION 7 0.0044
88 RETINAL SCAR 2 0.0043
89 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0043
90 MANUFACTURING ISSUE 2 0.0043
91 PERIPHERAL ARTERY OCCLUSION 6 0.0043
92 BLAST CELLS PRESENT 2 0.0042
93 CEREBRAL ARTERY STENOSIS 2 0.0041
94 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 2 0.0040
95 BUDD-CHIARI SYNDROME 1 0.0040
96 B-CELL APLASIA 1 0.0039
97 CRYPTOSPORIDIOSIS INFECTION 2 0.0038
98 BONE NEOPLASM 4 0.0037
99 HYPERAMYLASAEMIA 2 0.0037
100 SEROSITIS 2 0.0036
101 IMMUNE THROMBOCYTOPENIA 16 0.0035
102 TRANSAMINASES ABNORMAL 2 0.0034
103 AXONAL NEUROPATHY 3 0.0034
104 PNEUMONIA PNEUMOCOCCAL 5 0.0034
105 CARDIAC FUNCTION TEST ABNORMAL 1 0.0034
106 PNEUMONIA KLEBSIELLA 6 0.0033
107 GLOMERULOSCLEROSIS 2 0.0032
108 ARTERIAL THROMBOSIS 6 0.0031
109 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
110 PNEUMOCOCCAL SEPSIS 2 0.0030
111 PERICARDIAL EFFUSION 68 0.0029
112 KERATOACANTHOMA 2 0.0029
113 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 2 0.0028
114 DEPRESSIVE SYMPTOM 10 0.0028
115 OCULAR TOXICITY 3 0.0027
116 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
117 MENTAL FATIGUE 4 0.0027
118 THYROIDITIS 8 0.0027
119 ACCELERATED HYPERTENSION 1 0.0026
120 ALBUMIN URINE PRESENT 1 0.0026
121 HAEMATOTOXICITY 25 0.0026
122 SERONEGATIVE ARTHRITIS 3 0.0026
123 CARDIOVASCULAR SYMPTOM 1 0.0026
124 B PRECURSOR TYPE ACUTE LEUKAEMIA 1 0.0026
125 CONCOMITANT DISEASE PROGRESSION 5 0.0026
126 UTERINE ENLARGEMENT 2 0.0025
127 FULL BLOOD COUNT INCREASED 3 0.0025
128 PLATELET COUNT ABNORMAL 15 0.0025
129 IIIRD NERVE PARALYSIS 2 0.0025
130 PULMONARY ARTERIAL PRESSURE INCREASED 4 0.0025
131 POLYCYTHAEMIA VERA 2 0.0024
132 HYDROTHORAX 2 0.0024
133 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
134 ALVEOLAR OSTEITIS 1 0.0024
135 CRANIOFACIAL FRACTURE 2 0.0023
136 ABDOMINAL SEPSIS 2 0.0023
137 ABDOMINAL NEOPLASM 2 0.0022
138 STEATORRHOEA 6 0.0022
139 THROMBOCYTOSIS 8 0.0022
140 SECOND PRIMARY MALIGNANCY 18 0.0022
141 SOLAR LENTIGO 2 0.0021
142 BONE MARROW TRANSPLANT 4 0.0021
143 LYME DISEASE 7 0.0021
144 VASCULAR INJURY 3 0.0021
145 ANTIBIOTIC THERAPY 2 0.0020
146 BLINDNESS CORTICAL 1 0.0020
147 BRAIN STEM STROKE 1 0.0020
148 AORTIC STENOSIS 7 0.0020
149 CORONARY ARTERY STENOSIS 10 0.0020
150 INFECTIOUS PLEURAL EFFUSION 3 0.0020
151 CENTRAL NERVOUS SYSTEM VASCULITIS 1 0.0020
152 BRAIN STEM INFARCTION 2 0.0020
153 HYPERURICAEMIA 8 0.0019
154 CAROTID ARTERIOSCLEROSIS 2 0.0019
155 HEPATOTOXICITY 43 0.0019
156 DRUG RESISTANCE 49 0.0019
157 LEUKAEMIA 18 0.0019
158 HYPERTRIGLYCERIDAEMIA 11 0.0019
159 TUMOUR MARKER INCREASED 9 0.0019
160 CEREBRAL ARTERY OCCLUSION 2 0.0019
161 IRON OVERLOAD 2 0.0019
162 PLEURISY 11 0.0019
163 GASTRIC PERFORATION 5 0.0018
164 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
165 RETROPERITONEAL HAEMATOMA 4 0.0018
166 PLEURAL EFFUSION 109 0.0018
167 CONCOMITANT DISEASE AGGRAVATED 11 0.0018
168 LYMPHOCYTE COUNT ABNORMAL 2 0.0018
169 GASTRIC POLYPS 4 0.0018
170 RENAL COLIC 4 0.0018
171 VITH NERVE PARALYSIS 2 0.0018
172 CYTOMEGALOVIRUS COLITIS 4 0.0017
173 BURN ORAL CAVITY 1 0.0017
174 OPTIC NERVE INJURY 2 0.0017
175 DILATATION ATRIAL 2 0.0017
176 PERIPHERAL ISCHAEMIA 7 0.0017
177 HYPERTENSIVE EMERGENCY 2 0.0017
178 EMBOLISM ARTERIAL 2 0.0017
179 GASTROINTESTINAL TOXICITY 8 0.0017
180 BLOOD VISCOSITY INCREASED 1 0.0017
181 HAEMATOCRIT ABNORMAL 2 0.0016
182 DIASTOLIC DYSFUNCTION 5 0.0016
183 TALIPES 5 0.0016
184 LEUKOCYTOSIS 29 0.0016
185 BLOOD OSMOLARITY DECREASED 1 0.0016
186 SYSTEMIC CANDIDA 4 0.0016
187 ARTERITIS 1 0.0016
188 EXERCISE TOLERANCE DECREASED 9 0.0016
189 BLOOD BILIRUBIN ABNORMAL 2 0.0016
190 BLOOD PRESSURE MEASUREMENT 1 0.0016
191 PANCREATITIS 82 0.0015
192 EARLY SATIETY 3 0.0015
193 CHONDROCALCINOSIS 1 0.0015
194 THROMBOCYTOPENIA 171 0.0015
195 ACQUIRED GENE MUTATION 2 0.0015
196 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
197 LIPIDS INCREASED 3 0.0015
198 DRUG INTOLERANCE 141 0.0015
199 MENINGITIS VIRAL 2 0.0015
200 BRONCHIOLITIS 5 0.0014
201 ANAEMIA MACROCYTIC 3 0.0014
202 GRAFT VERSUS HOST DISEASE 10 0.0014
203 BITE 1 0.0014
204 PLATELET COUNT INCREASED 18 0.0014
205 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
206 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
207 AXILLARY PAIN 2 0.0013
208 PAPILLOEDEMA 6 0.0013
209 BONE MARROW DISORDER 4 0.0013
210 ASTIGMATISM 2 0.0013
211 BASOPHIL COUNT INCREASED 1 0.0013
212 CARDIAC TAMPONADE 6 0.0013
213 LACUNAR INFARCTION 3 0.0013
214 PNEUMONIA LEGIONELLA 2 0.0012
215 PULMONARY HYPERTENSION 26 0.0012
216 SKIN TOXICITY 7 0.0012
217 BREAST OPERATION 1 0.0012
218 PANCYTOPENIA 67 0.0012
219 SPLENOMEGALY 14 0.0012
220 PERICARDITIS 20 0.0012
221 LEUKAEMIA RECURRENT 2 0.0012
222 CEREBELLAR INFARCTION 2 0.0012
223 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
224 CHOROIDAL NEOVASCULARISATION 1 0.0012
225 SERUM FERRITIN DECREASED 2 0.0012
226 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
227 EXTREMITY NECROSIS 2 0.0011
228 VERTIGO POSITIONAL 2 0.0011
229 FOOD INTERACTION 2 0.0011
230 PRODUCT TAMPERING 2 0.0011
231 MONOPARESIS 2 0.0011
232 CALCIPHYLAXIS 2 0.0011
233 HYPERKERATOSIS 6 0.0011
234 TENOSYNOVITIS 3 0.0011
235 BIOPSY 1 0.0011
236 ADENOCARCINOMA GASTRIC 1 0.0011
237 ARTERIOSCLEROSIS 10 0.0011
238 CYSTOID MACULAR OEDEMA 2 0.0011
239 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
240 FULL BLOOD COUNT DECREASED 21 0.0010
241 MOTION SICKNESS 2 0.0010
242 COARCTATION OF THE AORTA 1 0.0010
243 BONE PAIN 60 0.0010
244 PANCREATIC DISORDER 5 0.0010
245 EMPYEMA 2 0.0010
246 HEPATIC ENZYME ABNORMAL 5 0.0010
247 ANTISOCIAL BEHAVIOUR 1 0.0010
248 RENAL HAEMORRHAGE 2 0.0010
249 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
250 CHANGE OF BOWEL HABIT 2 0.0010
251 POLYCYTHAEMIA 2 0.0010
252 ACUTE CORONARY SYNDROME 8 0.0010
253 BLOOD CREATININE DECREASED 3 0.0010
254 ASTERIXIS 1 0.0009
255 CARDIAC FAILURE CHRONIC 4 0.0009
256 LYMPHOCYTOSIS 2 0.0009
257 HYPOGAMMAGLOBULINAEMIA 6 0.0009
258 PROSTATE CANCER METASTATIC 3 0.0009
259 TEMPERATURE REGULATION DISORDER 2 0.0009
260 PSEUDOMEMBRANOUS COLITIS 2 0.0009
261 BRAIN FOG 14 0.0009
262 HEPATIC CYST 3 0.0009
263 PLATELET COUNT DECREASED 94 0.0009
264 NEUTROPHILIA 5 0.0009
265 MALIGNANT NEOPLASM PROGRESSION 90 0.0009
266 HAEMATOCRIT INCREASED 2 0.0009
267 SYNOVIAL CYST 4 0.0009
268 ACUTE MYOCARDIAL INFARCTION 25 0.0008
269 PRODUCT SUPPLY ISSUE 6 0.0008
270 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
271 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
272 ANURIA 7 0.0008
273 CARDIAC DYSFUNCTION 3 0.0008
274 PLATELET DISORDER 2 0.0008
275 CAROTID ARTERY DISEASE 1 0.0008
276 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
277 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
278 GINGIVAL DISORDER 3 0.0008
279 HEPATOSPLENOMEGALY 2 0.0008
280 BLOOD BILIRUBIN INCREASED 21 0.0008
281 VENTRICULAR DYSFUNCTION 2 0.0008
282 ADJUSTMENT DISORDER 1 0.0008
283 ANGINA UNSTABLE 5 0.0008
284 TREATMENT FAILURE 63 0.0008
285 NEPHROPATHY 7 0.0007
286 BONE MARROW FAILURE 15 0.0007
287 CEREBRAL INFARCTION 18 0.0007
288 SUBDURAL HAEMORRHAGE 2 0.0007
289 NEPHROTIC SYNDROME 5 0.0007
290 NONSPECIFIC REACTION 4 0.0007
291 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
292 HYPERTRANSAMINASAEMIA 5 0.0007
293 CARDIOVERSION 1 0.0007
294 APPENDIX DISORDER 1 0.0007
295 RETINAL VEIN OCCLUSION 2 0.0007
296 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
297 TRANSAMINASES INCREASED 15 0.0007
298 FULL BLOOD COUNT ABNORMAL 7 0.0007
299 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
300 DISEASE COMPLICATION 3 0.0007
301 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
302 CALCULUS URINARY 1 0.0006
303 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
304 MULTIPLE-DRUG RESISTANCE 2 0.0006
305 HEPATITIS B REACTIVATION 2 0.0006
306 NEPHROPATHY TOXIC 7 0.0006
307 LYMPHOCYTE COUNT INCREASED 2 0.0006
308 NEAR DEATH EXPERIENCE 2 0.0006
309 VENTRICULAR TACHYCARDIA 10 0.0006
310 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
311 PEPTIC ULCER 2 0.0006
312 THERAPY NON-RESPONDER 27 0.0006
313 MALIGNANT MELANOMA 8 0.0006
314 TOXIC ENCEPHALOPATHY 3 0.0006
315 DYSLIPIDAEMIA 3 0.0006
316 NEUTROPHIL COUNT DECREASED 24 0.0006
317 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
318 CEREBRAL ISCHAEMIA 3 0.0006
319 PERIPHERAL VASCULAR DISORDER 3 0.0006
320 APLASIA PURE RED CELL 2 0.0006
321 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
322 PYELONEPHRITIS 5 0.0006
323 LARGE INTESTINE PERFORATION 4 0.0006
324 CAROTID ARTERY STENOSIS 2 0.0006
325 MUSCULOSKELETAL PAIN 30 0.0006
326 RENAL IMPAIRMENT 48 0.0006
327 HAEMORRHAGIC DIATHESIS 2 0.0006
328 CARDIOTOXICITY 5 0.0006
329 CARDIAC ABLATION 1 0.0006
330 DERMATITIS ALLERGIC 7 0.0006
331 BONE LESION 2 0.0006
332 MYELODYSPLASTIC SYNDROME 8 0.0006
333 HEPATIC CYTOLYSIS 7 0.0005
334 BODY TEMPERATURE ABNORMAL 1 0.0005
335 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
336 HYPERTENSIVE CRISIS 6 0.0005
337 ANGIOPATHY 3 0.0005
338 HYDRONEPHROSIS 4 0.0005
339 CHOLECYSTITIS ACUTE 3 0.0005
340 THERAPEUTIC RESPONSE DECREASED 32 0.0005
341 GASTRIC ULCER 10 0.0005
342 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
343 ATRIOVENTRICULAR BLOCK 4 0.0005
344 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
345 ATROPHY 1 0.0005
346 BICYTOPENIA 1 0.0005
347 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
348 LYMPHOCYTE COUNT DECREASED 9 0.0005
349 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
350 NEUTROPENIA 69 0.0005
351 LOW BIRTH WEIGHT BABY 4 0.0005
352 POLYNEUROPATHY 6 0.0005
353 AZOTAEMIA 2 0.0005
354 OBSTRUCTION 2 0.0005
355 HYPERTENSION 106 0.0005
356 CARDIAC DISCOMFORT 1 0.0005
357 RECURRENT CANCER 2 0.0005
358 THERAPY INTERRUPTED 35 0.0005
359 ESCHERICHIA INFECTION 4 0.0005
360 GENERALISED OEDEMA 6 0.0005
361 SPINAL STENOSIS 2 0.0005
362 BLEPHAROSPASM 3 0.0005
363 MYALGIA 81 0.0005
364 ATRIAL TACHYCARDIA 1 0.0005
365 MUSCLE FATIGUE 2 0.0005
366 FEBRILE BONE MARROW APLASIA 2 0.0005
367 INTERVERTEBRAL DISC DISORDER 2 0.0005
368 HAEMOGLOBIN ABNORMAL 3 0.0005
369 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
370 SKIN HYPERPIGMENTATION 4 0.0005
371 CERVICAL DYSPLASIA 1 0.0005
372 IMMOBILE 2 0.0005
373 DIVERTICULUM INTESTINAL 2 0.0005
374 CATHETERISATION CARDIAC 2 0.0005
375 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
376 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
377 MYOSITIS 4 0.0004
378 SKIN INFECTION 5 0.0004
379 ANAL INCONTINENCE 4 0.0004
380 BLOOD LOSS ANAEMIA 1 0.0004
381 MYOCARDIAL ISCHAEMIA 5 0.0004
382 HAEMOGLOBIN INCREASED 2 0.0004
383 INFARCTION 3 0.0004
384 BRAIN OPERATION 1 0.0004
385 RENAL FAILURE 58 0.0004
386 LUMBAR VERTEBRAL FRACTURE 2 0.0004
387 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
388 NEPHROGENIC ANAEMIA 2 0.0004
389 DUODENAL ULCER 3 0.0004
390 GASTROINTESTINAL DISORDER 38 0.0004
391 ATAXIA 5 0.0004
392 SARCOIDOSIS 2 0.0004
393 LEUKOPENIA 21 0.0004
394 LIVER FUNCTION TEST INCREASED 9 0.0004
395 MYELOSUPPRESSION 15 0.0004
396 HUMERUS FRACTURE 2 0.0004
397 ATELECTASIS 4 0.0004
398 ENTEROCOCCAL INFECTION 2 0.0004
399 C-REACTIVE PROTEIN INCREASED 15 0.0004
400 MELAENA 9 0.0004
401 HEPATOMEGALY 4 0.0004
402 LABORATORY TEST ABNORMAL 12 0.0004
403 TOOTH DISORDER 9 0.0004
404 HYPERVOLAEMIA 2 0.0004
405 ACUTE PSYCHOSIS 1 0.0004
406 ANEURYSM 2 0.0004
407 ARRHYTHMIA 19 0.0004
408 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
409 NEUROTOXICITY 7 0.0004
410 WHITE BLOOD CELL COUNT DECREASED 43 0.0004
411 PRODUCT ADMINISTRATION ERROR 8 0.0004
412 DRUG TOLERANCE 2 0.0004
413 CARDIOVASCULAR DISORDER 10 0.0004
414 DEMENTIA 11 0.0004
415 FEBRILE NEUTROPENIA 26 0.0004
416 HOSPITALISATION 60 0.0004
417 ENDOCARDITIS 2 0.0004
418 THERAPY CESSATION 20 0.0004
419 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
420 CARDIAC FAILURE 31 0.0004
421 PERIORBITAL OEDEMA 2 0.0004
422 PETECHIAE 4 0.0004
423 SERUM FERRITIN INCREASED 2 0.0004
424 SUDDEN DEATH 4 0.0004
425 EATING DISORDER 8 0.0004
426 ANIMAL BITE 1 0.0004
427 BLOOD POTASSIUM ABNORMAL 1 0.0004
428 BLOOD DISORDER 3 0.0004
429 FLUID RETENTION 19 0.0004
430 FOOD POISONING 2 0.0004
431 BLOOD SODIUM INCREASED 1 0.0004
432 HYDROCEPHALUS 2 0.0004
433 CEREBROVASCULAR ACCIDENT 62 0.0004
434 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
435 NERVE INJURY 4 0.0004
436 ILLNESS 37 0.0004
437 INTRACRANIAL PRESSURE INCREASED 2 0.0004
438 CARPAL TUNNEL SYNDROME 5 0.0004
439 MACULAR OEDEMA 2 0.0004
440 OCULAR DISCOMFORT 4 0.0004
441 RED BLOOD CELL COUNT DECREASED 10 0.0003
442 ATRIAL FIBRILLATION 34 0.0003
443 CARDIAC OPERATION 3 0.0003
444 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
445 HERPES VIRUS INFECTION 2 0.0003
446 DIPLOPIA 9 0.0003
447 HYPERTHYROIDISM 5 0.0003
448 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
449 BILIARY COLIC 1 0.0003
450 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
451 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
452 SPINAL OSTEOARTHRITIS 3 0.0003
453 ANAEMIA 65 0.0003
454 FATIGUE 265 0.0003
455 CARDIOMYOPATHY 5 0.0003
456 ISCHAEMIC STROKE 6 0.0003
457 PULMONARY OEDEMA 15 0.0003
458 GOUT 6 0.0003
459 ATYPICAL PNEUMONIA 1 0.0003
460 ACNE CYSTIC 1 0.0003
461 GANGRENE 2 0.0003
462 CARDIAC DISORDER 31 0.0003
463 NEURALGIA 8 0.0003
464 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
465 IRON DEFICIENCY ANAEMIA 3 0.0003
466 BRAIN DEATH 1 0.0003
467 MUSCULOSKELETAL CHEST PAIN 5 0.0003
468 CHOLANGITIS 2 0.0003
469 ILEUS 4 0.0003
470 SWELLING OF EYELID 2 0.0003
471 NEUROPATHY PERIPHERAL 30 0.0003
472 OEDEMA 17 0.0003
473 ABSCESS 5 0.0003
474 CHOLESTASIS 6 0.0003
475 ACUTE RESPIRATORY FAILURE 6 0.0003
476 PANCREATITIS ACUTE 7 0.0003
477 BLOOD POTASSIUM INCREASED 5 0.0003
478 ABDOMINAL PAIN 71 0.0003
479 THERAPY CHANGE 3 0.0003
480 CORONAVIRUS INFECTION 2 0.0003
481 HAEMOGLOBIN DECREASED 31 0.0003
482 BLOOD PRESSURE ABNORMAL 6 0.0003
483 CARDIAC FAILURE ACUTE 2 0.0003
484 CYTOKINE RELEASE SYNDROME 6 0.0003
485 FACE OEDEMA 5 0.0003
486 BLOOD PRESSURE FLUCTUATION 7 0.0003
487 RESPIRATION ABNORMAL 2 0.0003
488 HYPERBILIRUBINAEMIA 3 0.0003
489 ADVERSE DRUG REACTION 26 0.0003
490 BLOOD CREATININE ABNORMAL 1 0.0003
491 ENCEPHALITIS 2 0.0003
492 HAIR GROWTH ABNORMAL 2 0.0003
493 ORAL DISCOMFORT 4 0.0003
494 EXTRASYSTOLES 2 0.0003
495 FOLLICULITIS 3 0.0003
496 MOUTH ULCERATION 6 0.0003
497 NEOPLASM MALIGNANT 19 0.0003
498 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
499 RETINAL HAEMORRHAGE 2 0.0003
500 PHARYNGITIS STREPTOCOCCAL 3 0.0003
501 VISUAL FIELD DEFECT 2 0.0003
502 TOOTHACHE 5 0.0003
503 BACK INJURY 3 0.0003
504 GASTROENTERITIS 4 0.0003
505 ORAL DISORDER 2 0.0003
506 TOOTH FRACTURE 3 0.0003
507 VIRAL INFECTION 9 0.0003
508 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
509 MYOCARDIAL INFARCTION 47 0.0003
510 HEPATIC CIRRHOSIS 5 0.0003
511 HEART RATE IRREGULAR 6 0.0003
512 PAROSMIA 2 0.0003
513 AUTOIMMUNE THYROIDITIS 1 0.0003
514 CHEMOTHERAPY 1 0.0003
515 CORONARY ARTERY DISEASE 8 0.0003
516 RHABDOMYOLYSIS 11 0.0003
517 AORTIC ANEURYSM 2 0.0003
518 HAEMODYNAMIC INSTABILITY 2 0.0003
519 MYOCARDITIS 3 0.0003
520 MUSCLE SPASMS 48 0.0003
521 BOWEL MOVEMENT IRREGULARITY 2 0.0003
522 GASTRIC HAEMORRHAGE 3 0.0003
523 LOWER LIMB FRACTURE 5 0.0003
524 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
525 PRODUCT USE COMPLAINT 4 0.0003
526 BACTERAEMIA 3 0.0003
527 RASH 110 0.0003
528 BLOOD ALBUMIN DECREASED 2 0.0003
529 CHOLECYSTITIS 3 0.0003
530 CEREBRAL HAEMORRHAGE 9 0.0003
531 MACULAR DEGENERATION 3 0.0003
532 CEREBRAL ATROPHY 1 0.0003
533 ATRIAL FLUTTER 2 0.0003
534 HYPOTHYROIDISM 8 0.0003
535 ABDOMINAL DISCOMFORT 42 0.0003
536 ARTHRALGIA 104 0.0002
537 THYROID CANCER 3 0.0002
538 LIVER DISORDER 11 0.0002
539 NOCTURIA 3 0.0002
540 PAIN IN JAW 7 0.0002
541 HYPERGLYCAEMIA 9 0.0002
542 ANGINA PECTORIS 7 0.0002
543 MUSCLE SPASTICITY 3 0.0002
544 CARDIOMEGALY 3 0.0002
545 ARTHRITIS BACTERIAL 1 0.0002
546 HYPERAESTHESIA 2 0.0002
547 ANAPHYLACTOID REACTION 1 0.0002
548 CHEST PAIN 45 0.0002
549 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
550 PERITONITIS 5 0.0002
551 LIP SWELLING 8 0.0002
552 FACIAL PARALYSIS 2 0.0002
553 NAUSEA 185 0.0002
554 DEATH 201 0.0002
555 DISEASE RECURRENCE 11 0.0002
556 SKIN SWELLING 2 0.0002
557 CHAPPED LIPS 1 0.0002
558 BONE CANCER 1 0.0002
559 BLOOD CREATININE INCREASED 15 0.0002
560 FLATULENCE 13 0.0002
561 TOOTH INFECTION 3 0.0002
562 TUMOUR LYSIS SYNDROME 2 0.0002
563 GRIP STRENGTH DECREASED 2 0.0002
564 SARS-COV-2 TEST POSITIVE 3 0.0002
565 BRADYCARDIA 12 0.0002
566 HEAD DISCOMFORT 4 0.0002
567 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
568 BLOOD CREATINE INCREASED 1 0.0002
569 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
570 HEADACHE 141 0.0002
571 NERVOUS SYSTEM DISORDER 7 0.0002
572 THROMBOSIS 18 0.0002
573 DYSPEPSIA 22 0.0002
574 HAEMARTHROSIS 2 0.0002
575 GASTROINTESTINAL INFECTION 2 0.0002
576 DIABETES MELLITUS 17 0.0002
577 GASTROENTERITIS VIRAL 4 0.0002
578 BLINDNESS 9 0.0002
579 ABDOMINAL DISTENSION 23 0.0002
580 IMPAIRED GASTRIC EMPTYING 3 0.0002
581 PRODUCT AVAILABILITY ISSUE 5 0.0002
582 ABDOMINAL HERNIA 1 0.0002
583 SKIN LESION 6 0.0002
584 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
585 ASTHENIA 82 0.0002
586 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
587 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
588 HUNGER 3 0.0002
589 RENAL DISORDER 10 0.0002
590 DIARRHOEA 138 0.0002
591 FLANK PAIN 2 0.0002
592 SQUAMOUS CELL CARCINOMA 2 0.0002
593 BLOOD PROLACTIN INCREASED 1 0.0002
594 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
595 FRACTURE 4 0.0002
596 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
597 EYE INFLAMMATION 2 0.0002
598 PULMONARY FIBROSIS 4 0.0002
599 HYPERCHOLESTEROLAEMIA 2 0.0002
600 MENTAL IMPAIRMENT 5 0.0002
601 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
602 OEDEMA PERIPHERAL 25 0.0002
603 ABDOMINAL PAIN UPPER 42 0.0002
604 ENCEPHALOPATHY 5 0.0002
605 KNEE OPERATION 2 0.0002
606 HOSPICE CARE 2 0.0002
607 HAEMATOCRIT DECREASED 4 0.0002
608 HAEMORRHAGE INTRACRANIAL 3 0.0002
609 PREMATURE BABY 6 0.0002
610 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
611 EMPHYSEMA 2 0.0002
612 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
613 SEPSIS 22 0.0002
614 TOOTH ABSCESS 2 0.0002
615 PALPITATIONS 23 0.0002
616 MOTOR DYSFUNCTION 2 0.0002
617 SLUGGISHNESS 2 0.0002
618 ERECTILE DYSFUNCTION 5 0.0002
619 CACHEXIA 1 0.0002
620 GYNAECOMASTIA 6 0.0002
621 ANAPHYLACTIC SHOCK 5 0.0002
622 TEMPERATURE INTOLERANCE 2 0.0002
623 INFLAMMATION 10 0.0002
624 VENTRICULAR EXTRASYSTOLES 2 0.0002
625 MENINGIOMA 3 0.0002
626 RESPIRATORY FAILURE 14 0.0002
627 APLASTIC ANAEMIA 1 0.0002
628 TACHYCARDIA 17 0.0002
629 DERMATITIS 4 0.0002
630 TRANSFUSION 2 0.0002
631 HEPATIC ENZYME INCREASED 13 0.0002
632 DYSURIA 7 0.0002
633 GASTRITIS 5 0.0002
634 VISION BLURRED 26 0.0002
635 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
636 PNEUMOTHORAX 3 0.0002
637 RENAL PAIN 2 0.0002
638 PREMATURE DELIVERY 3 0.0002
639 ANORECTAL DISCOMFORT 1 0.0002
640 BREAST PAIN 2 0.0002
641 COMPRESSION FRACTURE 1 0.0002
642 INFECTION 27 0.0002
643 HYPOACUSIS 8 0.0002
644 JAUNDICE 5 0.0002
645 RHINORRHOEA 12 0.0002
646 MENTAL DISORDER 8 0.0002
647 PRODUCT DISPENSING ERROR 4 0.0002
648 BLOOD PRESSURE INCREASED 28 0.0002
649 OESOPHAGITIS 2 0.0002
650 PHOTOSENSITIVITY REACTION 3 0.0002
651 MENTAL STATUS CHANGES 5 0.0002
652 BLOOD UREA INCREASED 3 0.0002
653 HEMIPARESIS 3 0.0002
654 PAIN IN EXTREMITY 52 0.0002
655 NEOPLASM 2 0.0002
656 EYELID OEDEMA 2 0.0002
657 SPINAL PAIN 2 0.0002
658 METASTASES TO LIVER 3 0.0002
659 DRUG INTERACTION 27 0.0002
660 ASCITES 5 0.0002
661 PNEUMONIA 55 0.0002
662 CONSTIPATION 37 0.0002
663 DYSPNOEA 96 0.0002
664 DISEASE PROGRESSION 20 0.0002
665 DYSPHAGIA 16 0.0002
666 BLOOD IRON DECREASED 2 0.0002
667 CATARACT OPERATION 1 0.0002
668 ALOPECIA 33 0.0002
669 COMA 8 0.0002
670 CARDIAC PACEMAKER INSERTION 1 0.0002
671 ACCIDENT 2 0.0002
672 BLOOD POTASSIUM DECREASED 5 0.0002
673 VOMITING 78 0.0002
674 HEPATIC FAILURE 5 0.0002
675 LOCALISED INFECTION 4 0.0002
676 ADRENAL INSUFFICIENCY 2 0.0002
677 DECREASED APPETITE 38 0.0002
678 BACK PAIN 38 0.0002
679 AGRANULOCYTOSIS 3 0.0002
680 HEPATIC FUNCTION ABNORMAL 6 0.0002
681 MIDDLE INSOMNIA 3 0.0002
682 BLISTER 9 0.0002
683 SWOLLEN TONGUE 5 0.0002
684 POISONING 2 0.0002
685 HEAD INJURY 5 0.0002
686 PULMONARY EMBOLISM 15 0.0002
687 PROTEINURIA 3 0.0002
688 HAEMATEMESIS 4 0.0002
689 INCREASED APPETITE 3 0.0002
690 ACUTE KIDNEY INJURY 24 0.0002
691 HERPES ZOSTER 9 0.0002
692 PERIPHERAL SWELLING 24 0.0002
693 HIP FRACTURE 5 0.0002
694 NIGHT SWEATS 5 0.0002
695 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
696 CARDIAC FLUTTER 1 0.0002
697 HAEMATOMA 4 0.0002
698 DYSPHONIA 9 0.0002
699 PYREXIA 53 0.0002
700 BRADYPHRENIA 1 0.0002
701 KIDNEY INFECTION 3 0.0002
702 ECZEMA 8 0.0002
703 EYE DISORDER 5 0.0002
704 PULMONARY CONGESTION 2 0.0002
705 APPETITE DISORDER 1 0.0002
706 SKIN DISORDER 5 0.0001
707 COGNITIVE DISORDER 7 0.0001
708 URINARY RETENTION 5 0.0001
709 QUALITY OF LIFE DECREASED 2 0.0001
710 TOXICITY TO VARIOUS AGENTS 25 0.0001
711 FEEDING DISORDER 3 0.0001
712 THROAT TIGHTNESS 4 0.0001
713 PNEUMONITIS 4 0.0001
714 POLLAKIURIA 6 0.0001
715 HAEMORRHAGE 15 0.0001
716 NECK PAIN 8 0.0001
717 BURNING SENSATION 10 0.0001
718 BLOOD TEST ABNORMAL 2 0.0001
719 SKIN REACTION 2 0.0001
720 SLEEP DISORDER 10 0.0001
721 SEASONAL ALLERGY 2 0.0001
722 SINUS TACHYCARDIA 2 0.0001
723 DRY EYE 7 0.0001
724 PRODUCT ADHESION ISSUE 5 0.0001
725 IRRITABLE BOWEL SYNDROME 3 0.0001
726 SUBDURAL HAEMATOMA 2 0.0001
727 CARDIOGENIC SHOCK 2 0.0001
728 IMPAIRED QUALITY OF LIFE 2 0.0001
729 SEPTIC SHOCK 6 0.0001
730 HYPOKINESIA 2 0.0001
731 LIVER FUNCTION TEST ABNORMAL 4 0.0001
732 PRODUCT STORAGE ERROR 12 0.0001
733 COVID-19 24 0.0001
734 DRUG INEFFECTIVE 179 0.0001
735 CEREBRAL DISORDER 1 0.0001
736 ARTHROPOD BITE 1 0.0001
737 PULMONARY MASS 2 0.0001
738 IMMUNODEFICIENCY 2 0.0001
739 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
740 SNEEZING 3 0.0001
741 BREAST TENDERNESS 1 0.0001
742 DYSPNOEA EXERTIONAL 5 0.0001
743 MUSCULAR WEAKNESS 15 0.0001
744 MEMORY IMPAIRMENT 18 0.0001
745 LYMPHOMA 2 0.0001
746 ANKLE FRACTURE 2 0.0001
747 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
748 APHTHOUS ULCER 1 0.0001
749 THERAPY PARTIAL RESPONDER 2 0.0001
750 PRURITUS 49 0.0001
751 RENAL CANCER 6 0.0001
752 SCIATICA 2 0.0001
753 METABOLIC ACIDOSIS 4 0.0001
754 WEIGHT INCREASED 28 0.0001
755 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
756 MOVEMENT DISORDER 4 0.0001
757 DIZZINESS 61 0.0001
758 MULTIPLE FRACTURES 2 0.0001
759 LUNG NEOPLASM MALIGNANT 5 0.0001
760 MALAISE 53 0.0001
761 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
762 PAIN 74 0.0001
763 PNEUMONIA ASPIRATION 3 0.0001
764 TYPE 2 DIABETES MELLITUS 4 0.0001
765 OFF LABEL USE 104 0.0001
766 GASTRIC CANCER 3 0.0001
767 OSTEOARTHRITIS 5 0.0001
768 CIRCULATORY COLLAPSE 2 0.0001
769 LOSS OF CONSCIOUSNESS 15 0.0001
770 MUSCULOSKELETAL DISCOMFORT 2 0.0001
771 BLOOD MAGNESIUM DECREASED 1 0.0001
772 PRODUCT DOSE OMISSION ISSUE 34 0.0001
773 VAGINAL HAEMORRHAGE 5 0.0001
774 RESPIRATORY TRACT INFECTION 3 0.0001
775 NEOPLASM PROGRESSION 4 0.0001
776 MUCOSAL INFLAMMATION 3 0.0001
777 SPEECH DISORDER 6 0.0001
778 JOINT STIFFNESS 3 0.0001
779 FALL 38 0.0001
780 EOSINOPHILIA 2 0.0001
781 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
782 ANGIOEDEMA 5 0.0001
783 LYMPHADENOPATHY 4 0.0001
784 SEIZURE 13 0.0001
785 DEHYDRATION 15 0.0001
786 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
787 GALLBLADDER DISORDER 2 0.0001
788 THIRST 2 0.0001
789 PAIN OF SKIN 3 0.0001
790 URINARY TRACT INFECTION 19 0.0001
791 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
792 RASH PRURITIC 6 0.0001
793 PELVIC PAIN 2 0.0001
794 TREATMENT NONCOMPLIANCE 6 0.0001
795 INCORRECT DOSE ADMINISTERED 25 0.0001
796 CARDIAC ARREST 9 0.0001
797 BRAIN NEOPLASM 1 0.0001
798 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
799 HYPERHIDROSIS 14 0.0001
800 ABNORMAL DREAMS 3 0.0001
801 HYPOKALAEMIA 5 0.0001
802 BLOOD GLUCOSE ABNORMAL 2 0.0001
803 CONJUNCTIVITIS 2 0.0001
804 CHEST DISCOMFORT 11 0.0001
805 BLOOD CHOLESTEROL INCREASED 5 0.0001
806 EPISTAXIS 8 0.0001
807 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
808 HYPONATRAEMIA 6 0.0001
809 TARDIVE DYSKINESIA 3 0.0001
810 DYSARTHRIA 4 0.0001
811 COLITIS 4 0.0001
812 OCULAR HYPERAEMIA 5 0.0001
813 INTENTIONAL DOSE OMISSION 3 0.0001
814 VISUAL IMPAIRMENT 13 0.0001
815 HYPOTENSION 21 0.0001
816 HYPERSOMNIA 3 0.0001
817 FEELING ABNORMAL 25 0.0001
818 BALANCE DISORDER 9 0.0001
819 AFFECT LABILITY 1 0.0001
820 WEIGHT DECREASED 29 0.0001
821 HERNIA 2 0.0001
822 INTERSTITIAL LUNG DISEASE 5 0.0001
823 MUSCULOSKELETAL STIFFNESS 9 0.0001
824 AUTOIMMUNE DISORDER 1 0.0001
825 LUNG DISORDER 5 0.0001
826 BLADDER DISORDER 1 0.0001
827 PRESCRIBED UNDERDOSE 2 0.0001
828 SYNCOPE 10 0.0001
829 APHASIA 3 0.0001
830 CELLULITIS 5 0.0001
831 ILL-DEFINED DISORDER 6 0.0001
832 TASTE DISORDER 2 0.0001
833 VERTIGO 6 0.0001
834 DISCOMFORT 6 0.0001
835 BODY TEMPERATURE INCREASED 2 0.0001
836 MOBILITY DECREASED 7 0.0001
837 DRY SKIN 13 0.0001
838 EMOTIONAL DISORDER 3 0.0001
839 CARDIO-RESPIRATORY ARREST 4 0.0001
840 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
841 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
842 MIGRAINE 9 0.0001
843 CYSTITIS 3 0.0001
844 CONTUSION 9 0.0001
845 POOR QUALITY SLEEP 2 0.0001
846 SKIN CANCER 2 0.0001
847 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
848 NASOPHARYNGITIS 17 0.0001
849 CHOLELITHIASIS 3 0.0001
850 OSTEONECROSIS 3 0.0001
851 BLOOD GLUCOSE FLUCTUATION 1 0.0001
852 HEART RATE INCREASED 9 0.0001
853 BLOOD GLUCOSE INCREASED 17 0.0001
854 GAIT INABILITY 3 0.0001
855 ORAL PAIN 2 0.0001
856 THROAT IRRITATION 4 0.0001
857 BLOOD CALCIUM DECREASED 1 0.0001
858 CARDIAC FAILURE CONGESTIVE 7 0.0001
859 SHOCK 2 0.0001
860 INSOMNIA 23 0.0001
861 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
862 HYPERKALAEMIA 3 0.0001
863 SURGERY 5 0.0001
864 CATARACT 5 0.0001
865 RASH ERYTHEMATOUS 4 0.0001
866 GAIT DISTURBANCE 16 0.0001
867 SKIN EXFOLIATION 7 0.0001
868 PARAESTHESIA 13 0.0001
869 BURSITIS 1 0.0001
870 FIBROMYALGIA 2 0.0001
871 PRESYNCOPE 2 0.0001
872 EYE SWELLING 3 0.0001
873 AGEUSIA 2 0.0001
874 INTESTINAL OBSTRUCTION 3 0.0001
875 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
876 BRAIN OEDEMA 1 0.0001
877 ABDOMINAL PAIN LOWER 2 0.0001
878 CHRONIC KIDNEY DISEASE 6 0.0001
879 SINUSITIS 8 0.0001
880 SKIN ULCER 2 0.0001
881 SWELLING FACE 5 0.0001
882 DEAFNESS 2 0.0001
883 BEDRIDDEN 1 0.0001
884 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
885 ADVERSE REACTION 1 0.0001
886 COUGH 21 0.0001
887 DEPRESSION 17 0.0001
888 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
889 FEAR 2 0.0001
890 DYSKINESIA 3 0.0001
891 LIMB INJURY 2 0.0001
892 HAEMATOCHEZIA 4 0.0001
893 ANAPHYLACTIC REACTION 4 0.0001
894 CONDITION AGGRAVATED 22 0.0001
895 PROCEDURAL PAIN 2 0.0001
896 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
897 URTICARIA 12 0.0001
898 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
899 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
900 PANCREATIC CARCINOMA 2 0.0001
901 ANOSMIA 1 0.0001
902 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
903 DYSSTASIA 2 0.0001
904 NASAL CONGESTION 4 0.0001
905 RENAL INJURY 2 0.0001
906 COLON CANCER 1 0.0001
907 LACRIMATION INCREASED 2 0.0001
908 SUICIDAL IDEATION 6 0.0001
909 NEPHROLITHIASIS 3 0.0001
910 SKIN DISCOLOURATION 3 0.0001
911 FEELING HOT 4 0.0001
912 SWELLING 6 0.0001
913 BASAL CELL CARCINOMA 1 0.0001
914 DRUG-INDUCED LIVER INJURY 2 0.0001
915 ARTHRITIS 5 0.0001
916 ANXIETY 18 0.0001
917 MOOD SWINGS 2 0.0001
918 DRY MOUTH 5 0.0001
919 BACK DISORDER 1 0.0001
920 EXPIRED PRODUCT ADMINISTERED 2 0.0001
921 HYPOAESTHESIA 9 0.0001
922 COAGULOPATHY 1 0.0001
923 FUNGAL INFECTION 2 0.0001
924 HYPERSENSITIVITY 11 0.0001
925 CANDIDA INFECTION 1 0.0001
926 PRODUCT USE ISSUE 11 0.0001
927 HAEMATURIA 2 0.0001
928 NERVOUSNESS 3 0.0001
929 RASH MACULAR 2 0.0001
930 DEPRESSED MOOD 3 0.0001
931 BONE DISORDER 1 0.0001
932 PANIC ATTACK 2 0.0001
933 SOMNOLENCE 11 0.0001
934 ADVERSE EVENT 5 0.0001
935 OROPHARYNGEAL PAIN 5 0.0001
936 MEDICATION ERROR 3 0.0001
937 INFLUENZA 6 0.0001
938 BACTERIAL INFECTION 1 0.0001
939 OXYGEN SATURATION DECREASED 3 0.0001
940 HALLUCINATION 4 0.0001
941 BLOOD SODIUM DECREASED 1 0.0001
942 UNEVALUABLE EVENT 4 0.0001
943 ACNE 4 0.0001
944 BLOOD URINE PRESENT 1 0.0001
945 EYE IRRITATION 3 0.0001
946 CHOKING 1 0.0001
947 BLADDER CANCER 3 0.0001
948 ABNORMAL BEHAVIOUR 2 0.0001
949 ABORTION SPONTANEOUS 2 0.0000
950 JOINT SWELLING 6 0.0000
951 CONFUSIONAL STATE 8 0.0000
952 STOMATITIS 3 0.0000
953 EXTRA DOSE ADMINISTERED 2 0.0000
954 OSTEOPOROSIS 2 0.0000
955 INFLUENZA LIKE ILLNESS 4 0.0000
956 RECTAL HAEMORRHAGE 2 0.0000
957 DEEP VEIN THROMBOSIS 3 0.0000
958 AMNESIA 3 0.0000
959 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
960 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
961 BLOOD PRESSURE DECREASED 3 0.0000
962 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
963 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
964 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
965 TREMOR 7 0.0000
966 SKIN BURNING SENSATION 3 0.0000
967 BRONCHITIS 3 0.0000
968 DYSGEUSIA 3 0.0000
969 HOT FLUSH 3 0.0000
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
971 ERYTHEMA 8 0.0000
972 DISTURBANCE IN ATTENTION 2 0.0000
973 EYE PAIN 2 0.0000
974 ASTHMA 4 0.0000
975 LETHARGY 2 0.0000
976 INTENTIONAL PRODUCT MISUSE 3 0.0000
977 CHILLS 4 0.0000
978 SUICIDE ATTEMPT 2 0.0000
979 BONE DENSITY DECREASED 1 0.0000
980 ANGER 1 0.0000
981 UNDERDOSE 2 0.0000
982 ACCIDENTAL OVERDOSE 1 0.0000
983 COMPLETED SUICIDE 2 0.0000
984 COLITIS ULCERATIVE 1 0.0000
985 ARTHROPATHY 1 0.0000
986 RHEUMATOID ARTHRITIS 2 0.0000
987 DRUG DEPENDENCE 2 0.0000
988 BREAST CANCER 1 0.0000